Pacitti David sold (to issuer) $19.2M of AVNS
Pacitti David (Chief Executive Officer) sold (to issuer) 766,924 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($19.17M total) across 2 trades on 2026-07-27.
How this was made
The 30-second read
Why it matters
The CEO sold a large block at a fixed price and reports 0 shares after the transaction, which may influence short-term sentiment but lacks any new fundamental information in the text.
Market read
Traders may monitor for follow-on insider activity or interpret the full exit as sentiment signal, but the filing alone does not change the company’s fundamentals.
What to watch
The filing does not state whether the sale was part of a structured program or buyback mechanics beyond the D code, and it provides no accompanying company performance or guidance changes.
Background
The article is an SEC Form 4 insider transaction disclosure for AVANOS MEDICAL, INC. (AVNS).
Ticker impact
CEO Pacitti David sold 766,924 shares to the issuer at $25.00/share, leaving 0 shares after the transaction.
Likely limited near-term impact; could slightly weigh on sentiment if traders interpret it as reduced insider confidence, but buyback-participation codes often mute that signal.
The filing is a Form 4 insider transaction with a D code (sale to issuer) and the CEO ends with 0 shares, but the text provides no earnings, guidance, or operational catalyst.
Market effects
No sector-level implications disclosed; this is company-specific insider transaction reporting.
None indicated.
None indicated.
Counterpoint
The D code suggests a sale to the issuer, which can reflect routine buyback participation or liquidity planning rather than a bearish view on fundamentals.
Key entities
- issuerAVANOS MEDICAL, INC.
Company whose CEO insider sale to issuer is disclosed via Form 4.
- insiderPacitti David
Chief Executive Officer who sold 766,924 shares to the issuer at $25.00/share.
